Literature DB >> 11099759

Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

V Russell1, S Allie, T Wiggins.   

Abstract

Spontaneously hypertensive rats (SHR) are used as a model for attention-deficit/hyperactivity disorder (ADHD) since SHR are hyperactive and they show defective sustained attention in behavioral tasks. Using an in vitro superfusion technique we showed that norepinephrine (NE) release from prefrontal cortex slices of SHR was not different from that of their Wistar-Kyoto (WKY) control rats when stimulated either electrically or by exposure to buffer containing 25 mM K(+). The monoamine vesicle transporter is, therefore, unlikely to be responsible for the deficiency in DA observed in SHR, since, in contrast to DA, vesicle stores of NE do not appear to be depleted in SHR. In addition, alpha(2)-adrenoceptor mediated inhibition of NE release was reduced in SHR, suggesting that autoreceptor function was deficient in prefrontal cortex of SHR. So, while DA neurotransmission appears to be down-regulated in SHR, the NE system appears to be under less inhibitory control than in WKY suggesting hypodopaminergic and hypernoradrenergic activity in prefrontal cortex of SHR. These findings are consistent with the hypothesis that the behavioral disturbances of ADHD are the result of an imbalance between NE and DA systems in the prefrontal cortex, with inhibitory DA activity being decreased and NE activity increased relative to controls.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099759     DOI: 10.1016/s0166-4328(00)00291-6

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  30 in total

1.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.

Authors:  Josephine Elia; Joseph T Glessner; Kai Wang; Nagahide Takahashi; Corina J Shtir; Dexter Hadley; Patrick M A Sleiman; Haitao Zhang; Cecilia E Kim; Reid Robison; Gholson J Lyon; James H Flory; Jonathan P Bradfield; Marcin Imielinski; Cuiping Hou; Edward C Frackelton; Rosetta M Chiavacci; Takeshi Sakurai; Cara Rabin; Frank A Middleton; Kelly A Thomas; Maria Garris; Frank Mentch; Christine M Freitag; Hans-Christoph Steinhausen; Alexandre A Todorov; Andreas Reif; Aribert Rothenberger; Barbara Franke; Eric O Mick; Herbert Roeyers; Jan Buitelaar; Klaus-Peter Lesch; Tobias Banaschewski; Richard P Ebstein; Fernando Mulas; Robert D Oades; Joseph Sergeant; Edmund Sonuga-Barke; Tobias J Renner; Marcel Romanos; Jasmin Romanos; Andreas Warnke; Susanne Walitza; Jobst Meyer; Haukur Pálmason; Christiane Seitz; Sandra K Loo; Susan L Smalley; Joseph Biederman; Lindsey Kent; Philip Asherson; Richard J L Anney; J William Gaynor; Philip Shaw; Marcella Devoto; Peter S White; Struan F A Grant; Joseph D Buxbaum; Judith L Rapoport; Nigel M Williams; Stanley F Nelson; Stephen V Faraone; Hakon Hakonarson
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

2.  Conditioned inhibition in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  John T Green; Amy C Chess; Cynthia J Conquest; Brittney A Yegla
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

3.  Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin.

Authors:  Wenhua Liu; Eunice Y Yuen; Patrick B Allen; Jian Feng; Paul Greengard; Zhen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

4.  Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.

Authors:  Britahny M Baskin; Bríd Á Nic Dhonnchadha; Linda P Dwoskin; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2017-07-20       Impact factor: 4.530

5.  Validation of a method to assess ADHD-related impulsivity in animal models.

Authors:  Elizabeth Watterson; Gabriel J Mazur; Federico Sanabria
Journal:  J Neurosci Methods       Date:  2015-04-01       Impact factor: 2.390

6.  Atomoxetine-induced life-threatening long QT syndrome.

Authors:  M Stuhec; V Svab
Journal:  Ir J Med Sci       Date:  2013-02-19       Impact factor: 1.568

7.  Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.

Authors:  Yukio Ago; Masato Umehara; Kosuke Higashino; Shigeru Hasebe; Kazumi Fujita; Kazuhiro Takuma; Toshio Matsuda
Journal:  Neurochem Res       Date:  2014-03-15       Impact factor: 3.996

Review 8.  Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism.

Authors:  Robert D Rogers; Frederick G Moeller; Alan C Swann; Luke Clark
Journal:  Alcohol Clin Exp Res       Date:  2010-06-07       Impact factor: 3.455

Review 9.  Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.

Authors:  Stephanie M Groman; Alex S James; J David Jentsch
Journal:  Neurosci Biobehav Rev       Date:  2008-08-22       Impact factor: 8.989

10.  Effect of dioxins on regulation of tyrosine hydroxylase gene expression by aryl hydrocarbon receptor: a neurotoxicology study.

Authors:  Eiichi Akahoshi; Seiko Yoshimura; Saeko Uruno; Mitsuko Ishihara-Sugano
Journal:  Environ Health       Date:  2009-06-06       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.